s
Alphyn to Present Poster on Zabalafin Hydrogel Clinical Results at European Academy of Dermatology and Venereology Congress 2024
27-08-2024, 13:52
– ANNAPOLIS, Md., Aug. 27, 2024 /PRNewswire/ — Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that data from its Phase 2a human clinical trial of Zabalafin Hydrogel (AB-101a) in atopic dermatitis (AD) will be presented at the upcoming European Academy of Dermatology and Venereology (EADV) Congress 2024 in Amsterdam, September […] L'articolo Alphyn to Present Poster on Zabalafin Hydrogel Clinical Results at European Academy of Dermatology and Venereology Congress 2024 proviene da La Ragione.
CONTINUA A LEGGERE
11
0
0
Guarda anche
La Ragione
08:34
L’Italia fragile
La Ragione
07:33
Sicilia: spento l’incendio a Favignana, anche oggi allerta
La Ragione
01:43
Champions dolceamara per l’Atalanta, 0-0 contro l’Arsenal
La Ragione
Ieri, 23:43
G7 cultura, Giuli accoglie delegazioni a Napoli
La Ragione
Ieri, 22:43
La Russa “Non sono complottista, centrodestra non è accerchiato”
La Ragione
Ieri, 20:43